Given that colony number is not affected but colony size is affected by treatment with FAK TKI in combination with erlotinib, our data supports the notion that the combination treatment can also block 3D growth and proliferation of NSCLC cells, again with the most pronounced effects in A549 cells. This evidence concerns the gene PTK2 and non-small cell lung carcinoma.